top of page
News, Events and Updates
Search
Dec 10, 2018
Anavex Life Sciences to Announce 2018 Fiscal Year End Financial Results on Wednesday, 12/12/2018
Nov 8, 2018
Anavex Life Sciences Strengthens its Scientific Advisory Board with Distinguished Researcher for Cli
Oct 29, 2018
First Patient Enrolled in Anavex Life Sciences Phase 2 Clinical Trial of ANAVEX®2-73
Oct 25, 2018
Anavex Life Sciences Presents New Three-Year, Longitudinal Clinical Efficacy Data for ANAVEX®2-73
Oct 18, 2018
Anavex Life Sciences Announces FDA Approval of IND for Phase 2 Trial ANAVEX®2-73 for Rett Syndrome
Sep 25, 2018
Anavex Life Sciences to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
Aug 28, 2018
First Patient Enrolled in Anavex Life Sciences Phase 2b/3 Clinical Trial of ANAVEX®2-73
Aug 8, 2018
Anavex Life Sciences Reports Fiscal Third Quarter 2018 Financial Results
Aug 6, 2018
Anavex Life Sciences to Announce Fiscal Third Quarter 2018 Financial Results on Thursday, 8/9/2018
Jul 24, 2018
Anavex Life Sciences Presents New Data Identifying Treatment Response Biomarkers in Alzheimer’s Dise
Jul 8, 2018
Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX®2-73
18
19
20
21
22
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
